Intel CEO targeted by Trump has been in power struggle with tech company's board for months: report — Negative
INTC New York Post — August 08, 2025The tensions center on whether Intel should remain in the costly business of manufacturing its own chips, according to the Wall Street Journal.

Nvidia (NASDAQ: NVDA) Bull, Base, & Bear Price Prediction and Forecast (Aug 8) — Negative
NVDA 24/7 Wall Street — August 08, 2025The trade war with China was tough on Nvidia Corp. (NASDAQ: NVDA) investors.

ExxonMobil Guyana Begins Production at Fourth Offshore Guyana Project — Neutral
XOM Business Wire — August 08, 2025SPRING, Texas--(BUSINESS WIRE)--ExxonMobil Guyana started production today at Yellowtail, the fourth oil development in Guyana's offshore Stabroek block. Yellowtail's ONE GUYANA floating production storage and offloading (FPSO) vessel joins the Destiny, Unity, and Prosperity FPSOs, bringing total installed capacity in Guyana to above 900,000 barrels of oil per day. “Yellowtail's ahead-of-schedule startup is a significant milestone for ExxonMobil and the people of Guyana,” said Dan Ammann, pres.

Why Centrus Energy Stock Is Powering Higher This Week — Positive
LEU The Motley Fool — August 08, 2025Reversing course from its 13.6% decline last week, Centrus Energy (LEU 1.10%) stock has rocketed steadily higher throughout this week. With the nuclear fuel company's report of second-quarter 2025 financial results earlier this week providing one catalyst, positive coverage of the stock from analysts has provided more fuel for the stock's rise.

4 High-Yield Blue Chips Near 52-Week Lows: All Are Strong Buys Now — Positive
HRL PEP PFE TAP 24/7 Wall Street — August 08, 2025Blue-chip stocks are shares of large, well-established, financially stable companies with a history of consistent and reliable performance.

New England Realty Associates LP Announces Third-Quarter Distribution on Class A Units and Depositary Receipts — Neutral
NEN PRNewsWire — August 08, 2025ALLSTON, Mass. , Aug. 8, 2025 /PRNewswire/ -- On September 30, 2025, New England Realty Associates Limited Partnership (NYSE MKT: NEN) will make its quarterly distribution to its Class A Limited Partners and holders of Depositary Receipts of record as of September 15, 2025.

TEM Earnings Rally: A.I. Use in Health Care, Drug Discovery — Positive
TEM Schwab Network — August 08, 2025George Congdon joins Morning Movers to look at an AI player in the healthcare space: Tempus AI (TEM). Shares of TEM have rallied higher after its 2Q earnings.

Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript — Neutral
LFCR Seeking Alpha — August 08, 2025Universal Electronics Inc. (UEIC) Q4 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Paul Josephs - President, CEO & Director Ryan D. Lake - EVP & CFO Conference Call Participants Matthew Gregory Hewitt - Craig-Hallum Capital Group LLC, Research Division Maxwell Andrew Smock - William Blair & Company L.L.C.

Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates — Negative
CGC Zacks Investment Research — August 08, 2025Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.37 per share a year ago.

CPI Card Group Inc. (PMTS) Lags Q2 Earnings and Revenue Estimates — Negative
PMTS Zacks Investment Research — August 08, 2025CPI Card Group Inc. (PMTS) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.51 per share a year ago.

SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates — Positive
SRDX Zacks Investment Research — August 08, 2025SurModics (SRDX) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.21 per share. This compares to a loss of $0.27 per share a year ago.

AMC Networks (AMCX) Tops Q2 Earnings and Revenue Estimates — Positive
AMCX Zacks Investment Research — August 08, 2025AMC Networks (AMCX) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $1.24 per share a year ago.

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons — Neutral
NVO GlobeNewsWire — August 08, 2025Bagsværd, Denmark, 8 August 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk.

Top 2 Materials Stocks That May Fall Off A Cliff In August — Negative
HL MP Benzinga — August 08, 2025As of Aug. 8, 2025, two stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Bain Capital Specialty Finance: I Remain Bullish After Q2 Report — Positive
BCSF Seeking Alpha — August 08, 2025Bain Capital Specialty Finance has issued a solid Q2 report, triggering a positive reaction by the market. This validates my thesis on BCSF - i.e., tangible discount and strongly covered dividend should likely warrant an upside or at least protected downside. In the article, I discuss why, after digesting the Q2 report, I still remain bullish on BCSF.

DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript — Neutral
XRAY Seeking Alpha — August 08, 2025DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Daniel T. Scavilla - President, CEO & Director Matthew E.

Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference — Neutral
ANIX PRNewsWire — August 08, 2025Dr. Wenham is Principal investigator on Anixa's CAR-T therapy for Ovarian Cancer SAN JOSE, Calif. , Aug. 8, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced Dr. Robert Wenham, Chair of the Gynecologic Oncology Program at Moffitt Cancer Center and principal investigator for the Company's ongoing ovarian cancer CAR-T therapy Phase 1 clinical trial, will be presenting at the 13th Annual Ovarcoming Cancer Conference, being held September 18 – 19, 2025, virtually and in-person at the Briar Club in Houston, Texas.

Apple's Tremendous Lead in Global Smartphone Revenue — Neutral
AAPL 24/7 Wall Street — August 08, 2025Most public measurements of smartphone sales data focus on unit sales. In every quarter in memory, Apple Inc.

Dividend Cut Alert: 2 BDCs With Unsustainable Yields — Negative
FSK OCSL Seeking Alpha — August 08, 2025BDC sector faces significant risks: high valuations, spread tightening, and thin dividend coverage leave little margin of safety. Lower base rates will likely be soon here, creating further headwinds for BDCs and pressuring net investment income and dividends. I recommend avoiding speculative BDCs, focusing on high-quality names with robust portfolios and strong dividend coverage at a discount.

Terreno Realty Corporation Sells Property in Santa Fe Springs, CA for $11.0 Million — Neutral
TRNO Business Wire — August 08, 2025BELLEVUE, Wash.--(BUSINESS WIRE)--Terreno Realty Corporation Sells Property in Santa Fe Springs, CA for $11.0 Million.
